Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls

Human Molecular Genetics

Volumn 17, Issue 13, 2008, Pages 1988-1993

  Simón Sánchez, Javier ^a,b   Singleton, Andrew B ^a,c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; SERINE PROTEINASE OMI; TYROSINE;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GERMANY; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUTATION; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; SERINE ENDOPEPTIDASES;

EID: 45749135862     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn096     Document Type: Article

References (26)

1. Waters, C.H. and Miller, C.A. (1994) Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann. Neurol., 35, 59-64.
2. Payami, H., Bernard, S., Larsen, K., Kaye, J. and Nutt, J. (1995) Genetic anticipation in Parkinson's disease. Neurology, 45, 135-138.
3. Plante-Bordeneuve, V., Taussig, D., Thomas, F., Ziegler, M. and Said, G. (1995) A clinical and genetic study of familial cases of Parkinson's disease. J. Neurol. Sci., 133, 164-172.
4. Wszolek, Z.K., Pfeiffer, B., Fulgham, J.R., Parisi, J.E., Thompson, B.M., Uitti, R.J., Calne, D.B. and Pfeiffer, R.F. (1995) Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology, 45, 502-505.
5. Golbe, L.I., Di Iorio, G., Sanges, G., Lazzarini, A.M., La Sala, S., Bonavita, V. and Duvoisin, R.C. (1996) Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann. Neurol., 40 767-775.
6. Maraganore, D.M., Schaid, D.J., Rocca, W.A. and Harding, A.E. (1996) Anticipation in familial Parkinson's disease: A reanalysis of 13 United Kingdom kindreds. Neurology, 47, 1512-1517.
7. Morrison, P.J., Godwin-Austen, R.B. and Raeburn, J.A. (1996) Familial autosomal dominant dopa responsive Parkinson's disease in three living generations showing extreme anticipation and childhood onset. J. Med. Genet., 33, 504-506.
8. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
9. Polymeropoulos, M.H., Higgins, J.J., Golbe, L.I., Johnson, W.G., Ide, S.E., Di Iorio, G., Sanges, G., Stenroos, E.S., Pho, L.T., Schaffer, A.A. et al. (1996) Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science, 274, 1197-1199.
10. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. (2003) α-Synuclein locus triplication causes Parkinson's disease. Science, 302, 841.
11. Paisan-Ruiz, C., Jain, S., Evans, E.W., Gilks, W.P., Simon, J., van der Brug, M., Lopez de Munain, A., Aparicio, S., Gil, A.M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 44, 595-600.
12. Zimprich, A., Biskup, S., Leirner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Caine, D.B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44, 601-607.
13. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizurio, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
14. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158-1160.
15. Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299, 256-259.
16. Gray, C.W., Ward, R.V., Karran, E., Turconi, S., Rowles, A., Viglienghi, D., Southan, C., Barton, A., Fantom, K.G., West, A. et al. (2000) Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem., 267, 5699-5710.
17. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K. et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375, 754-760.
18. Park, H.J., Seong, Y.M., Choi, J.Y., Kang, S. and Rhim, H. (2004) Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci. Lett., 357, 63-67.
19. Jones, J.M., Datta, P., Srinivasula, S.M., Ji, W., Gupta, S., Zhang, Z., Davies, E., Hajnoczky, G., Saunders, T.L., Van Keuren, M.L. et al. (2003) Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature, 425, 721-727.
20. Martins, L.M., Morrison, A., Klupsch, K., Fedele, V., Moisoi, N., Teismann, P., Abuin, A., Grau, E., Geppert, M., Livi, G.P. et al. (2004) Neuroprotective role of the Reaper-related serine protease HtrA2/ Omi revealed by targeted deletion in mice. Mol. Cell Biol., 24 9848-9862.
21. Strauss, K.M., Martins, L.M., Plun-Favreau, H., Marx, F.P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Muller, T., Bornemann, A. et al. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet., 14, 2099-2111.
22. Gasser, T., Muller-Myhsok, B., Wszolek, Z.K., Oehlmann, R., Calne, D.B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P. and Horstmann, R.D. (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet., 18, 262-265.
23. West, A.B., Zimprich, A., Lockhart, P.J., Farrer, M., Singleton, A., Holtom, B., Lincoln, S., Hofer, A., Hill, L., Muller-Myhsok, B. et al. (2001) Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes. Eur. J. Hum. Genet., 9, 659-666.
24. Pankratz, N., Uniacke, S.K., Halter, C.A., Rudolph, A., Shults, C.W., Conneally, P.M., Foroud, T. and Nichols, W.C. (2004) Genes influencing Parkinson disease onset: Replication of PARK3 and identification of novel loci. Neurology, 62, 1616-1618.
25. Dupont, W.D. and Plummer, W.D Jr (1990) Power and sample size calculations. A review and computer program. Control Clin. Trials, 11, 116-128.
26. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Mailer, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.